BioLife Solutions (BLFS)
(Real Time Quote from BATS)
$23.06 USD
+0.18 (0.79%)
Updated Aug 7, 2024 09:52 AM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 42% (105 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.69 | 9.99 |
Current Quarter Estimate | -0.14 | 5.88 | 61.00 |
Year Ago Quarter Estimate | -0.23 | 4.88 | 54.84 |
Next Quarter Estimate | -0.11 | 7.06 | 63.00 |
Next Year Estimate | -0.21 | 39.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 69.08 | 14.80 | 15.67 |
Next Year | 55.32 | 26.20 | 11.34 |
Last 5 Years | -389.00 | 3.70 | 8.10 |
Next 5 Years | NA | 15.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 3.11 | 2.10 |
Price/Cash Flow (MRFY) | NA | 11.31 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -45.84% | -1.09% |
Return on Equity (TTM) | -12.89% | 10.15% |
Debt to Equity (MRQ) | NA | 33.03 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.